Stocktoria
Janux Therapeutics, Inc. JANX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-06-11
Janux Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,344,007 | $98.2M | 3.78% |
| Point72 Asset Management, L.P. | 1,993,837 | $30.6M | 3.22% |
| CITADEL ADVISORS LLC | 1,264,837 | $19.4M | 2.04% |
| TWO SIGMA INVESTMENTS, LP | 1,207,250 | $18.5M | 1.95% |
| D. E. Shaw & Co., Inc. | 1,096,509 | $16.8M | 1.77% |
| MILLENNIUM MANAGEMENT LLC | 504,544 | $7.7M | 0.81% |
| AQR CAPITAL MANAGEMENT LLC | 108,077 | $1.7M | 0.17% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.